Artelo Biosciences
(NASDAQ) ARTL
Artelo Biosciences Financials at a Glance
Market Cap
$4.39M
Revenue (TTM)
$0.00
Net Income (TTM)
-$13.47M
EPS (TTM)
-$38.92
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$1.27
Volume
123,694.277
Open
$1.28
Price
$1.27
Volume
123,694.277
Open
$1.28
Previous Close
$1.26
Daily Range
$1.25 - $1.29
52-Week Range
$1.19 - $85.80
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$1.27
Volume
123,694.277
Open
$1.28
Previous Close
$1.26
Daily Range
$1.25 - $1.29
52-Week Range
$1.19 - $85.80
Estimated Earnings Date
Aug 12, 2026
ARTL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Artelo Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Gregory D. Gorgas, MBA
Website
www.artelobio.comHeadquarters
Solana Beach, CA 92075, US
ARTL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-368%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.39M
Shares Outstanding
3.49M
Volume
123.69K
Avg. Volume
3.37M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$11.40M
EBITDA
-$12.54M
Operating Cash Flow
-$8.52M
Capital Expenditure
$0.00
Free Cash Flow
-$8.52M
Cash & ST Invst.
$600.00K
Total Debt
$693.00K
Artelo Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.39M
N/A
Market Cap/Employee
$731.97K
N/A
Employees
6
N/A
Net Income
-$2.96M
-24.7%
EBITDA
-$2.83M
-19.5%
Quarterly Fundamentals
Total Cash
$10.27M
+1277.1%
Total Debt
$755.00K
+694.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$18.00K
-69.5%
Short Term Debt
$737.00K
+1947.2%
Return on Assets
-1.08%
N/A
Return on Invested Capital
-1.75%
N/A
Free Cash Flow
-$1.19M
+25.4%
Operating Cash Flow
-$1.19M
+25.4%